Epilepsy
specific21
Centers
0
Active Trials
$32M
Cancer Funding
Top Centers for Epilepsy(21)
Ranked by research excellence score (trials · grants · publications). Methodology →
| # | Center | Score |
|---|---|---|
| 1 | NCI Comprehensive Active Research Program | 69.0 |
| 2 | NCI Comprehensive Active Research Program | 67.4 |
| 3 | UC Davis Comprehensive Cancer CenterSacramento, CA NCI Comprehensive Active Research Program | 65.7 |
| 4 | UCLA Jonsson Comprehensive Cancer CenterLos Angeles, CA NCI Comprehensive Active Research Program | 64.0 |
| 5 | Upstate Cancer CenterSyracuse, NY Active Research Program | 62.4 |
| 6 | NCI Comprehensive Active Research Program | 60.7 |
| 7 | UF Health Cancer InstituteGainesville, FL NCI Clinical Active Research Program | 59.0 |
| 8 | The Ohio State University Comprehensive Cancer Center - James Cancer Hospital & Solove Research InstituteColumbus, OH NCI Comprehensive Active Research Program | 57.4 |
| 9 | University of Colorado Cancer CenterAurora, CO NCI Comprehensive Active Research Program | 55.7 |
| 10 | Siteman Cancer CenterSt. Louis, MO NCI Comprehensive Active Research Program | 54.0 |
| 11 | Georgia Cancer Center, Augusta UniversityAugusta, GA Active Research Program | 52.4 |
| 12 | Duke Cancer InstituteDurham, NC NCI Comprehensive Active Research Program | 50.7 |
| 13 | Holden Comprehensive Cancer CenterIowa City, IA NCI Comprehensive Active Research Program | 49.0 |
| 14 | NCI Basic_laboratory Active Research Program | 47.4 |
| 15 | The University of Arizona Cancer CenterTucson, AZ NCI Comprehensive Active Research Program | 45.7 |
| 16 | Mayo Clinic Comprehensive Cancer CenterRochester, MN NCI Comprehensive Active Research Program | 44.0 |
| 17 | NCI Clinical | 39.0 |
| 18 | Fred & Pamela Buffett Cancer CenterOmaha, NE NCI Clinical | 39.0 |
| 19 | University of Illinois Cancer CenterChicago, IL | 39.0 |
| 20 | UAMS Winthrop P. Rockefeller Cancer InstituteLittle Rock, AR | 39.0 |
| 21 | Mayo Clinic Comprehensive Cancer Center, FloridaJacksonville, FL | 39.0 |
Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →